Charpentier granted new CRISPR/Cas9 patent

ERS Genomics has announced a new CRISPR/Cas9 US patent for use of the gene-editing technology in a single guide format.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

ERS Genomics signs CRISPR deal with Lonza

14 December 2018 ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.

Biotechnology

University of California granted fifth CRISPR patent

28 May 2019 The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier.

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

More on this story

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Biotechnology

University of California granted fifth CRISPR patent

28 May 2019 The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier.

Biotechnology

ERS Genomics signs CRISPR deal with Lonza

14 December 2018 ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.

More on this story

Genetics

Danish biotech company secures CRISPR licence

4 June 2019 Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Biotechnology

University of California granted fifth CRISPR patent

28 May 2019 The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier.

Biotechnology

ERS Genomics signs CRISPR deal with Lonza

14 December 2018 ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.